Recruiting
Phase 3

Metformin

Sponsor:

Donald Mabbott

Code:

NCT05230758

Conditions

Medulloblastoma, Childhood

Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 7 - 21

Healthy Volunteers: Not accepted

Interventions

Metformin hydrochloride (HCl) 500mg tablet

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Donald Mabbott on 2025-07-16.